These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34626859)

  • 1. Treatment Patterns and Disease Burden Associated with Multiple-Inhaler Triple-Therapy Use in Asthma.
    Oppenheimer J; Bogart M; Bengtson LGS; White J; Sundquist K; Lima R; Averell C
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):485-494.e5. PubMed ID: 34626859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting.
    Halpin DMG; Rothnie KJ; Banks V; Czira A; Compton C; Wood R; Tritton T; Massey O; Wild R; Snowise N; Nikitin K; Sharma R; Ismaila AS; Vogelmeier CF
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2417-2429. PubMed ID: 36185170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study.
    Mannino D; Bogart M; Wu B; Germain G; Laliberté F; MacKnight SD; Jung Y; Stiegler M; Duh MS
    Respir Med; 2022 Jun; 197():106807. PubMed ID: 35429764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population.
    Bogart M; Stanford RH; Laliberté F; Germain G; Wu JW; Duh MS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():343-352. PubMed ID: 30863037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand.
    Xu X; Milea D; Navarro Rojas AA; Braganza A; Holbrook T; Marett B; Young R; Scott RJ; Gribben B
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1835-1850. PubMed ID: 34177262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
    Alcázar-Navarrete B; Jamart L; Sánchez-Covisa J; Juárez M; Graefenhain R; Sicras-Mainar A
    Chest; 2022 Nov; 162(5):1017-1029. PubMed ID: 35787391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management.
    Busse WW; Abbott CB; Germain G; Laliberté F; MacKnight SD; Jung Y; Duh MS; Averell CM
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2904-2913.e6. PubMed ID: 35752431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
    Lee CH; Kim MS; Yeo SH; Rhee CK; Park HW; Yang BR; Lee J; Cho EY; Xu X; Navarro Rojas AA; Shantakumar S; Milea D; Choi NK
    Respir Res; 2022 Sep; 23(1):231. PubMed ID: 36064539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice.
    Sansbury LB; Bains C; Lipson DA; Ismaila AS; Landis SH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1255-1264. PubMed ID: 33986594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings.
    Cazzola M; Calzetta L; Rinaldi B; De Novellis V; Rogliani P; Matera MG
    Expert Rev Respir Med; 2022; 16(11-12):1205-1212. PubMed ID: 36629483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain.
    Barrecheguren M; Monteagudo M; Miravitlles M; Flor X; Núñez A; Osorio J; Muñoz X; Ojanguren I
    NPJ Prim Care Respir Med; 2022 Mar; 32(1):11. PubMed ID: 35273167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease.
    Sicras Mainar A; Huerta A; Navarro Artieda R; Monsó E; Landis SH; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2121-2129. PubMed ID: 31571848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy.
    Numbere B; Liu Y; Zhang S; Czira A; Lu Y
    BMJ Open Respir Res; 2024 Mar; 11(1):. PubMed ID: 38448044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world users of triple therapy for asthma in the US.
    Hansel NN; Abbott CB; Averell CM; Germain G; Laliberté F; Mahendran M; Duh MS; Settipane RA
    Am J Manag Care; 2024 Feb; 30(2):74-81. PubMed ID: 38381542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England.
    Sansbury LB; Wood RP; Anley GA; Nam Y; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2795-2808. PubMed ID: 34675504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics, treatment patterns, disease burden, and persistence/adherence in patients with asthma initiating inhaled triple therapy: real-world evidence from Japan.
    Suzuki T; Fairburn-Beech J; Sato K; Kaise T
    Curr Med Res Opin; 2020 Jun; 36(6):1049-1057. PubMed ID: 32363945
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study.
    Bogart M; Stanford RH; Reinsch T; Hull M; Buikema A; Hulbert E
    Respir Med; 2018 Sep; 142():73-80. PubMed ID: 30170806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study).
    Deslee G; Fabry-Vendrand C; Poccardi N; Thabut G; Eteve Pitsaer C; Coriat A; Renaudat C; Maguire A; Pinto T
    BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37263738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
    Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
    Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.